Changes are coming to Nebraska Medicine’s senior leadership organizational chart.
Beginning Tuesday, Nov. 1, Michael Ash, MD, will move from his current role as executive vice president–chief transformation officer to executive vice president–chief operating officer for Nebraska Medicine. As announced on Oct. 25, Cory Shaw, executive vice president–chief operating officer, will depart at the end of November after being recruited as the new president and CEO of UC Health in Cincinnati. He will support the transitions through November.
As Dr. Ash begins service as COO, the position of chief transformation officer will be eliminated. Dr. Ash will continue to lead Information Technology, in addition to inpatient, ambulatory and procedural areas. The changes will result in new reporting structures in several areas.
• Harris Frankel, MD, will expand his role as chief medical and external affairs officer and will assume executive leadership of marketing and communications, community engagement and philanthropy.
• Anna Cramer, JD, will add compliance to her leadership of the legal team as chief legal and compliance officer.
• The diversity, equity and inclusion team will join human resources with Frank Venuto’s leadership.
• Facilities management and planning will report to Chief Financial Officer Stephanie Daubert.
• The quality, experience and effectiveness team will report to Chief Nursing Officer Sue Nuss, PhD.
Vice presidents and directors already have begun working to ensure a smooth transition throughout the next month. An updated organizational chart will be posted on the leadership page of the Nebraska Medicine NOW on Nov. 1, when the changes take effect.
“As I shared during our most recent forum, change is constant, especially in health care,” says CEO Jim Linder, MD. “And we can choose to face it with uncertainty or positive anticipation. As we wish Cory well in his new leadership role in Ohio, we also continue to evolve as a health system. I encourage all of us to approach these changes with positivity and support. Together, we’ll continue to provide Serious Medicine. Extraordinary Care.”